Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery

UCHealth·Jun 16

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A new weight-loss drug, retatrutide, has shown significant effectiveness in clinical trials, with reports of weight loss ranging up to 85 pounds. The drug's performance is being compared to that of weight-loss surgery, with some outlets suggesting it may be on par with surgical outcomes. The extent of weight loss varies, but the drug appears to have yielded substantial results, with some sources indicating average weight loss of 85 pounds.

Full coverage

People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says

NBC News·May 21

Retatrutide, ‘Triple G’ Anti-Obesity Drug, Leads to ‘Huge’ Weight Loss of Up to 85 Pounds

TODAY.com·May 21

Experimental Drug Yields Dramatic Weight Loss

The New York Times·May 22

Experimental drug helps patients lose 85 pounds on average, study finds

Scripps News·May 21

View original report at UCHealth ↗

Fetching the latest headlines…

Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery

Full coverage

People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says

Weight Loss: Lilly's New Drug Helped People Lose Up to 85 Pounds

Eli Lilly says next-generation weight loss drug clears crucial obesity trial

New weight-loss shot appears to outperform other obesity drugs on market

A New Obesity Drug Delivered Surgery-Level Weight Loss in Clinical Trials

Retatrutide, ‘Triple G’ Anti-Obesity Drug, Leads to ‘Huge’ Weight Loss of Up to 85 Pounds

Experimental Drug Yields Dramatic Weight Loss

Experimental drug helps patients lose 85 pounds on average, study finds